Four-year cardiac geometry, blood pressure, and immune profiles after multisystem inflammatory syndrome in children
Yıldız Ekemen Keleş1, Özgür Özdemir Şimşek2, Yeliz Sevinç3
1Department of Pediatric Infectious Diseases, Bakırçay University Çiğli Training and Research Hospitalhttps://ror.org/017v96566, İzmir, Türkiye.
Insights
Multisystem inflammatory syndrome in children (MIS-C) can cause ventricular enlargement years later, but this may be physiological scaling. Continued long-term surveillance is recommended for these pediatric patients.
Area of Science:
- Pediatric Cardiology
- Pediatric Infectious Diseases
- Pediatric Critical Care Medicine
Background:
- Multisystem inflammatory syndrome in children (MIS-C) is a serious condition affecting multiple organs.
- Understanding the long-term cardiovascular impact of MIS-C is crucial for patient management.
Purpose of the Study:
- To evaluate left ventricular geometry, hemodynamic load, and inflammatory markers in children with a history of MIS-C.
- To determine the long-term cardiovascular sequelae of MIS-C.
Main Methods:
- Retrospective study of pediatric patients with prior MIS-C diagnosis.
- Utilized echocardiography, ambulatory blood pressure monitoring, and laboratory assessments for follow-up.
- Analyzed correlations between body mass index, inflammatory markers, and cardiac parameters.
Main Results:
- Thirty patients with MIS-C were evaluated a median of 48 months post-diagnosis.
- Positive correlations were found between body mass index and left ventricular dimensions/mass.
- Lymphocyte count independently predicted left ventricular end-diastolic diameter.
Conclusions:
- Ventricular enlargement in children with MIS-C history appears to be physiological scaling, not persistent hypertrophy, four years post-diagnosis.
- These findings highlight the need for ongoing long-term cardiovascular surveillance in children recovering from MIS-C.
Background:
To evaluate left ventricular geometry, haemodynamic load, and inflammatory markers with multisystem inflammatory syndrome in children.
Methods:
This retrospective study included paediatric patients with a prior diagnosis of multisystem inflammatory syndrome in children who underwent follow-up echocardiography, ambulatory blood pressure monitoring, and laboratory assessments.
Results:
Thirty patients (mean age 12.9 ± 5.0 years; 18 boys) were evaluated, including eight (26.7%) who had required an ICU stay during the acute phase. The median interval since the diagnosis of multisystem inflammatory syndrome in children was 48 months (interquartile range 47-50). Body mass index was positively correlated with left ventricular end-diastolic diameter (r = 0.577, p = 0.001), left ventricular end-systolic diameter (r = 0.522, p = 0.002), interventricular septal thickness (r = 0.565, p = 0.001), posterior wall thickness (r = 0.610, p < 0.001), and left ventricular mass (r = 0.594, p = 0.001). Body mass index z-score correlated with interleukin-6 (r = 0.415, p = 0.023), while lymphocyte count correlated inversely with left ventricular end-diastolic diameter (r = -0.559, p = 0.001) and left ventricular mass (r = -0.631, p < 0.001). Multivariate analysis identified lymphocyte count as the only independent predictor of left ventricular end-diastolic diameter [β = -0.492, 95% confidence interval = -0.589 to -0.078, p = 0.013].
Conclusions:
Four years after multisystem inflammatory syndrome in children, ventricular enlargement appears to reflect physiological scaling rather than persistent hypertrophy, supporting the need for continued long-term surveillance in this population.
More Related Videos
08:51Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
Published on: September 20, 2024
12:36Single-cell Analysis of Immunophenotype and Cytokine Production in Peripheral Whole Blood via Mass Cytometry
Published on: June 26, 2018
Related Concept Videos
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Myocarditis II: Clinical Features and Diagnostic Tests
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Myocarditis I: Introduction
Rheumatic Heart Disease I: Introduction
